Abstract:LPA activated the NF‐κB signaling pathway via LPA1/3, leading to an increase in CCL2 secretion, which was the main driver in ESCC progression. Background Lysophosphatidic acid (LPA) is a small bioactive lipid which acts as a potent regulator in various tumor progressions through six G‐protein‐coupled receptors (LPA1–LPA6). Our previous study demonstrated that the LPA‐producing enzyme, autotaxin (ATX), was upregulated in esophageal squamous cell carcinoma (ESCC) and ATX high expression levels indicated a poor prognosis. Esophageal squamous cell carcinoma is a type of malignant tumor which originates from epithelial cells. Its progression can be affected by the interaction between cancer cells and normal cells. However, the impact of LPA on the interaction between esophageal epithelial cells and cancer cells in the development of ESCC remains uncertain. Methods MTS and Edu assays were performed to determine ESCC cell proliferation in culture medium (CM) derived from LPA‐stimulated esophageal epithelial cells (Het‐1a). A wound healing assay, transwell migration and an invasion assay were performed to assess the metastatic ability of ESCC cells. Cytokine array analysis was conducted to detect the differentially secreted cytokines in CM. The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were utilized to uncover the pathways and cytokines that are influenced by LPA in ESCC. Immunohistochemical staining was employed to measure the expression of ATX and CCL2 in early‐stage ESCC. Quantitative real‐time PCR, western blot, enzyme‐linked immunosorbent assay and an antibody neutralization assay were employed to measure the mechanism of LPA‐mediated communication between epithelial cells and cancer cells. Results Functional experiments showed that exposing ESCC cancer cells to CM from LPA‐treated Het‐1a results in promoting proliferation, migration, invasion and epithelial–mesenchymal transition processes. Using cytokine array analysis, we discovered that LPA triggers the release of multiple cytokines from epithelial cells. After screening of the TCGA and GEO databases, CCL2 was identified and found to be correlated with ATX expression in ESCC. Furthermore, CCL2 levels in both mRNA expression and secretion were observed to be upregulated in epithelial cells upon stimulation with LPA. Blocking CCL2 effectively reduced the pro‐migration influence of CM derived from LPA‐treated Het‐1a. Mechanism studies have demonstrated that LPA activated the NF‐κB signaling pathway through LPA1/3, ultimately causing an increase in CCL2 expression and secretion in Het‐1a. Conclusions Our findings, taken together, demonstrate that CM from LPA‐treated esophageal epithelial cells plays a significant role in promoting the progression of ESCC, with CCL2 acting as the primary regulator.

Lysophosphatidic Acid Induces the Migration and Invasion of SGC-7901 Gastric Cancer Cells Through the LPA2 and Notch Signaling Pathways

Influence of Up-Regulation of Notch Ligand DLL4 on Biological Behaviors of Human Gastric Cancer Cells.

LPAR2 receptor stimulates progression of gastric cancer through β‐catenin signaling pathway

Lysophosphatidic Acid Stimulates Activation of Focal Adhesion Kinase and Paxillin and Promotes Cell Motility, via LPA1–3, in Human Pancreatic Cancer

LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments

Lysophosphatidic acid induced HeLa-S3 cell migration

Alteration of Cellular Energy Metabolism through LPAR2-Axin2 Axis in Gastric Cancer

Lysophosphatidic Acid-induced EGFR Transactivation Promotes Gastric Cancer DNA Replication Through Up-Regulation of Geminin

Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.

Lysophosphatidic acid promotes ESCC progression by increasing the level of CCL2 secreted by esophageal epithelial cells

PLCB1 Enhances Cell Migration and Invasion in Gastric Cancer Via Regulating Actin Cytoskeletal Remodeling and Epithelial–Mesenchymal Transition

Effects of Lysophosphatidic Acid on Human Colon Cancer Cells and Its Mechanisms of Action

Elevated Notch-1 expression promotes the lymph node metastasis of gastric cancer and the Notch-1-PTEN-ERK1/2 signalling axis promotes the progression of gastric cancer

Abstract 1571: Upregulation of phosphoglyceric acid mutase (PGAM)-1 is related to lymph node metastasis in gastric cancer

Lysophosphatidic Acid Induces Integrin Β6 Expression in Human Oral Squamous Cell Carcinomas Cells Via LPAR1 Coupling to Gαi and Downstream SMAD3 and ETS-1 Activation

Heparanase Promotes Human Gastric Cancer Cells Migration and Invasion by Increasing Src and P38 Phosphorylation Expression

LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration

Lymphatic Endothelial Cell-Secreted Cxcl1 Stimulates Lymphangiogenesis and Metastasis of Gastric Cancer

The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis

The NOTCH Ligand JAGGED2 Promotes Pancreatic Cancer Metastasis Independent of NOTCH Signaling Activation

Notch2 Regulates Matrix Metallopeptidase 9 Via PI3K/AKT Signaling in Human Gastric Carcinoma Cell MKN-45.